Information Center
Your Health. Your Family. Your Choice.
|
|
National Vaccine Information Center Your Health. Your Family. Your Choice. |
MedAlerts Home |
| Case Details |
Administered by: Unknown Purchased by: Unknown
Life Threatening? No Write-up: Information has been received from a specialist and from the health authority, concerning a 20 year old female with asthenia, anxiety/overwork syndrome and psychologic fragility since May 2008 and a history of cardiac murmur during childhood, who in OCT-2008 was vaccinated with the first dose of GARDASIL. The patient had no adverse effects after this dose. Concomitant therapy included BUSPAR, LEXOMIL, magnesium (unspecified) (+) pyridoxine hydrochloride and hormonal contraceptives (unspecified). On 27-DEC-2008 the patient was vaccinated with the second dose of GARDASIL, batch number not reported. It was reported that 3 days after the second dose of GARDASIL, i.e. in JAN-2009 the patient presented with hyperthermia at 38 C associated with breathlessness. After a malaise during shopping on 01-JAN-2009 the patient consulted her general practitioner; she had tremor and tachycardia. Blood analysis was performed on 03-JAN-2009 and revealed a slight hyperleukocytosis (12.4 103/mm3). By the evening on 03-JAN-2009 the patient presented with a malaise again but with no dyspnea and after taking BUSPAR. 2 hours later the intervention of EMUR (emergency medical mobile unit) could lead to recuperate a sinusal rhythm. Continuous arrhythmia with atrial fibrillation was diagnosed. The patient was transferred to medical intensive care service: she presented with bilateral mydriasis, hypothermia at 33.7 C, the result of measure of sugar in her blood was increased at 3.18 and she had cyanosis of face, ears, and extremities. Radiological examinations revealed a pneumopathy of the right middle pulmonary lobe and septal hypokinesia with paradoxical septal. There was no cocaine and no benzodiazepines. The patient presented with multiorgan failure under high dose of amines and then she dies in spite of the cardiopulmonary by-pass and extra corporeal oxygenation assistance. An autopsy was performed (unspecified date) and found no cause of death, also reported as information on autopsy was still awaited. Other business partner numbers include: E2009-00502. Additional information has been requested. | ||||||||||||||||||||
Administered by: Unknown Purchased by: Unknown
Life Threatening? No Write-up: Information has been received from an Agency concerning a 14 year old female who was vaccinated with GARDASIL, lot # not available. Subsequently the patient died. The cause of death was unknown. Additional information has been requested. | ||||||||||||||||||||
Administered by: Unknown Purchased by: Unknown
Life Threatening? No Write-up: Information has been received from a gynaecologist concerning an approximate 14 year old female patient with a history of bronchial asthma, who was vaccinated with a first dose of GARDASIL (lot # not reported) IM into the upper arm on 09-JUN-2009. On 12-JUN-2009, the patient experienced an asthmatic attack of which she died. The patient had no long-term medication for the asthma but only on occasion. Concomitant medication included hormonal contraceptives (unspecified). Reportedly, an autopsy was performed. The result is not yet known. A causal relation to the GARDASIL vaccine was considered unlikely by the vaccinating physician. Follow-up information received on 22-JUN-2009: Exact birth date, initials, height (158 cm) and weight (50 kg) as well as lot # 1477U, batch # NH25390 were provided. Following information gathered by phone from the reporting physician, the girl experienced the asthmatic attack at home and an emergency doctor was called. He was not able to arrest the attack and resuscitation was unsuccessful. Other business partner''s numbers included: E2009-05085. | ||||||||||||||||||||
Administered by: Unknown Purchased by: Unknown
Life Threatening? No Write-up: Information has been received from a nurse practitioners'' patient who heard on radio that "HPV vaccine killed someone in the country". The cause of death was unknown. The reporter was not sure if the vaccine was GARDASIL or CERVARIX. Attempts are being made to verify the existence of an identifiable patient. Additional information has been requested. | ||||||||||||||||||||
Administered by: Unknown Purchased by: Unknown
Life Threatening? No Write-up: Information has been received from a 22 year old female with a history of precancerous cells present (caused by HPV) in 2004 and partial cervicectomy who in approximately January 2008, was vaccinated with the first dose of GARDASIL, lot # not available. In approximately March 2008, the patient was vaccinated with the second dose of GARDASIL, lot # not available. In July 2008 the patient found out she was pregnant. In September 2008 the patient was vaccinated with the third dose of GARDASIL, lot # not available (on the recommendation of her physician). In approximately January 2009 the patient went into premature labor (at 23 and a half weeks gestation) and her son was still born. Upon internal review, 23 and a half weeks gestation and stillbirth were considered to be other important medical events. No further information is available. This is one of several reports received from the same source. | ||||||||||||||||||||
Administered by: Unknown Purchased by: Unknown
Life Threatening? No Write-up: Information was reported in a newspaper article that a 14 year old female patient who on an unspecified date was vaccinated with a dose of GARDASIL vaccine (lot number, date, route and site not reported). Subsequently the patient experienced auto-immune symptoms and died 21 months later. The article also discussed the multiple sclerosis of other 5 patient while on therapy with GARDASIL vaccine (WAES 0912USA01664, WAES 0912USA02322, WAES 0912USA02323, WAES 0912USA02324, and WAES 0912USA02325, WAES 0912USA02639, WAES 0912USA02640, WAES 0912USA02641, WAES 0912USA02642 and WAES 0912USA02643. No further information is available. | ||||||||||||||||||||
Administered by: Unknown Purchased by: Unknown
Life Threatening? No Write-up: Information has been received from a physician concerning a previous healthy 17 year old female patient with no relevant medical history who on 22-MAY was vaccinated intramuscularly with her first dose of GARDASIL (Lot # 654740/0859F) (Batch # NE29660) (Injection site was not reported). Concomitant therapy included VALETTE. On 11-JUL-2007 the reporter was informed by the patient''s mother that her daughter was hospitalized due to bone inflammation. On 15-JUL-2007, approximately 7 weeks post vaccination, the patient died of unknown cause. An autopsy was carried out, but the result was not known to the reporter up to the time of reporting. A lot check has been initiated. Other business partner numbers include E2009-11667. Additional information has been requested. | ||||||||||||||||||||
Administered by: Unknown Purchased by: Unknown
Life Threatening? Yes Write-up: Information has been received from from a physician concerning a 12 year old school going girl of class eight of a village. On 20-JUL-2009, the patient received first dose of GARDASIL in the school. During the process of community mobilization for second dose of GARDASIL, the female health worker was informed that on 06-SEP-2009, the patient accidentally fell in open well (granite quarry filled with water), drowned and expired. This event occurred 49 days of receiving first dose of GARDASIL. The female health worker informed the Medical Officer in-charge, which was then communicated to District Immunization Officer. The medical officer in-charge investigated the death and completed first information report and determined that death was not related to the vaccine. | ||||||||||||||||||||
Administered by: Unknown Purchased by: Unknown
Life Threatening? Yes Write-up: Information has been received from a physician concerning a 14 year old school going girl (ID#: -3/09) who received the first dose of GARDASIL in left deltoid, on 16-JUL-2009. Concomitant therapy included indigo. During the process of community mobilization for second dose, the female health worker was informed that the patient committed suicide on 29-AUG-2009 by consuming insecticide. The postmortem was performed on 30-AUG-2009. This event occurred after 45 days of receiving first dose of GARDASIL. The female health worker informed the medical officer in charge, which was then communicated to Immunization Officer. The medical officer in charge investigated the death and completed first information report as per guidelines and determined the death was not related to the vaccine and so no further investigations were done. No further information is available. | ||||||||||||||||||||
Administered by: Unknown Purchased by: Unknown
Life Threatening? Yes Write-up: Information has been received from a physician concerning a 13 year old school girl studying in class nine of health center. On 17-JUL-2009, patient received first dose of GARDASIL left deltoid. Concomitant medications included chloroquine, RANTAC, paracetamol, "IV fluids RL" and aminophyline drip. During the process of community mobilization for second dose of GARDASIL the multipurpose health worker was informed that the patient developed fever on 01-AUG-2009 and was treated by local registered medical practitioner (RMP). The patient did not recover and was admitted to the hospital on 08-AUG-2009. On the same day, GENTAMYCIN was given. She developed dyspnoea and went into coma and so was referred and was shifted to another hospital where she expired on 08-AUG-2009 at around 9:00 pm. The cause of death was determined as "death due to viral fever". The information was provided from patient''s maternal grandparents as she was staying with them. This event occurred after 23 days of receiving first dose of GARDASIL. The female health worker informed the medical officer in charge and he investigated the death and completed the first information report as per AEFI guidelines. The case sheet mentions as "pyrexia of unknown origin". This information was then communicated to district immunization officer, who determined that the death was not related to the vaccine and so a decision was taken to close the investigation. | ||||||||||||||||||||
Link To This Search Result:
https://www.medalerts.org/vaersdb/findfield.php?EVENTS=ON&PAGENO=17&SYMPTOMS[]=Death_%2810011906%29&VAX[]=HPV4
Copyright ©
2019 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166